Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells
MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in...
Saved in:
Published in | Transplant immunology Vol. 69; p. 101461 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.12.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0966-3274 1878-5492 1878-5492 |
DOI | 10.1016/j.trim.2021.101461 |
Cover
Loading…
Abstract | MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.
•MiR-155 and prenyltransferase formed a feedback loop in human T lymphocytes.•Inhibition of the feedback loop between miR-155/protein prenylation affected Th17 and Treg cell polarization in vitro.•MiR-155 levels and protein prenylation were increased and interacted in aGVHD mice.•Suppression of miR-155 or protein prenylation in T lymphocytes alleviated murine aGVHD.•Interventions targeting the miR-155/protein prenylation feedback loop affected Th17 and Treg cell polarization in aGVHD mice. |
---|---|
AbstractList | AbstractMicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4 +CD25 hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment.MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4+CD25hi regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. •MiR-155 and prenyltransferase formed a feedback loop in human T lymphocytes.•Inhibition of the feedback loop between miR-155/protein prenylation affected Th17 and Treg cell polarization in vitro.•MiR-155 levels and protein prenylation were increased and interacted in aGVHD mice.•Suppression of miR-155 or protein prenylation in T lymphocytes alleviated murine aGVHD.•Interventions targeting the miR-155/protein prenylation feedback loop affected Th17 and Treg cell polarization in aGVHD mice. MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte differentiation, however the mechanism remains elusive. In this study, we found that the expression of miR-155 and protein prenyltransferases in peripheral blood T lymphocytes of aGVHD mice was significantly increased. Suppression of miR-155 by antagomir-155 could remarkably reduce prenyltransferases mRNA and protein expression in T lymphocytes of aGVHD mice. Conversely, prenyltransferase inhibitors significantly reduced the level of miR-155. Inhibition of this feedback loop of miR-155 and protein prenylation in aGVHD mice led to improved survival and lower aGVHD histopathology scores and significantly induced T cell deficient differentiation towards T helper 17 (Th17) cells and titled differentiation towards CD4 CD25 regulatory T (Treg) cells. Furthermore, the immunoregulatory effects and protection from aGVHD of prenyltransferase inhibitors could be reversed by the addition of miR-155. The dual treatment of prenylation inhibitors and antagomir-155 showed synergistic effects on T polarization and protection from aGVHD. Consistent with the in vivo changes, inhibition of this feedback loop of miR-155 and protein prenylation affected Th17 and Treg cell polarization in vitro. Our data suggest that miR-155 and protein prenylation may constitute a feedback loop that amplifies immune and inflammatory responses in subjects with aGVHD, and they may serve as potential targets for aGVHD prophylaxis and treatment. |
ArticleNumber | 101461 |
Author | Zhang, Ran Wu, Qiuling Huang, Zhenli Xia, Linghui Zang, Sibin Wang, Xiaoxiao |
Author_xml | – sequence: 1 givenname: Xiaoxiao surname: Wang fullname: Wang, Xiaoxiao organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China – sequence: 2 givenname: Ran surname: Zhang fullname: Zhang, Ran organization: Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China – sequence: 3 givenname: Zhenli surname: Huang fullname: Huang, Zhenli organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China – sequence: 4 givenname: Sibin surname: Zang fullname: Zang, Sibin organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China – sequence: 5 givenname: Qiuling surname: Wu fullname: Wu, Qiuling email: 1999XH0535@hust.edu.cn organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China – sequence: 6 givenname: Linghui surname: Xia fullname: Xia, Linghui email: linghuixia@hust.edu.cn organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 JieFang Avenue,Wuhan 430022, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34487810$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1vFCEYhYmpsdvqH_DCcOnNrMB8MGOMSdP40aSJia7XhIF3dtiysAKzZv-TP1Jmt3rRxMrNm5DnHOAcLtCZ8w4QeknJkhLavNksUzDbJSOMzhtVQ5-gBW15W9RVx87QgnRNU5SMV-foIsYNIYTVHX-GzsuqyhglC_Trxo2mN8l4h_2A0wh4a74WtK6xdBrvgk9gXJ7gDlYesQFA91LdYev9DktrYW9kAo2lmhLgdZBDKvYQ4hSL0ceEtYkgI2Tz4Kf1iAOsp9nLrY_n9dJKp_KE9BPA4RUewe4gYMqPd1hlHiuwNj5HTwdpI7y4n5fo-8cPq-vPxe2XTzfXV7eFqhqWim7oalr1HbBmaGqpVNNxXZMeSMOlHhjVNeesbStaAeugLUmTIQbtACXXmpeX6PXJNz__xwQxia2J8w2kAz9FwWpOaF4lzeire3Tqt6DFLjciw0H8STgD7ASo4GMMMPxFKBFzjWIj5hrFXKM41ZhF7QORMumYfgrS2Mel705SyAHtDQQRlYGcrzYBVBLam8fl7x_IlTXOKGnv4ABx46fgcvSCisgEEd_mLzb_MEYJyRZ1Nnj7b4P_nf4b0r_ibA |
CitedBy_id | crossref_primary_10_4110_in_2025_25_e11 crossref_primary_10_1007_s00011_022_01643_6 crossref_primary_10_1016_j_genrep_2024_102037 |
Cites_doi | 10.1371/journal.ppat.1003222 10.1182/blood-2008-08-172155 10.1111/1755-5922.12282 10.1080/08830180903093796 10.1111/imm.12468 10.1182/blood-2014-07-586511 10.4048/jbc.2018.21.2.112 10.1038/nrc3151 10.1182/blood-2011-10-387522 10.1126/science.1139253 10.1016/j.cytogfr.2011.05.002 10.1128/MCB.06597-11 10.1182/blood-2011-03-340315 10.1016/S0140-6736(09)60237-3 10.1016/S1083-8791(03)00087-9 10.1056/NEJMra1609337 10.1182/blood-2011-02-334904 10.1016/j.cell.2012.04.005 10.1182/blood-2007-08-106005 10.1182/blood-2013-06-510586 10.18632/oncotarget.15579 10.1182/blood-2008-06-162420 10.1371/journal.ppat.1006790 10.3324/haematol.2012.065789 10.1016/j.cell.2008.12.027 10.1126/scisignal.2005970 10.1182/blood-2014-12-617258 10.1186/s12943-014-0284-y 10.1038/nchembio834 10.1128/MCB.00941-08 10.1101/gad.209619.112 10.1038/nrd2221 10.1016/j.coph.2012.06.013 10.1016/j.atherosclerosis.2007.07.031 10.1016/j.cell.2004.12.035 10.1038/nature01158 10.1146/annurev.bi.65.070196.001325 |
ContentType | Journal Article |
Copyright | 2021 Elsevier B.V. Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.trim.2021.101461 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1878-5492 |
EndPage | 101461 |
ExternalDocumentID | 34487810 10_1016_j_trim_2021_101461 S0966327421001015 1_s2_0_S0966327421001015 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 36B 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS CNWQP COF CS3 DU5 EBS EBX EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMG HMK HMO HVGLF HZ~ IHE J1W KOM LUGTX M29 M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SES SEW SIN SPCBC SSH SSI SSZ T5K UHS UNMZH WUQ Z5R ~G- AFCTW AGRNS RIG AACTN AAIAV ABDBF ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW EAD EAP EAS EFLBG EHN EMB EMK EPT ESX LCYCR SV3 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c462t-9f9514b9e26f65acc697d50be067adf21d577288414e29e8306acc2e8fe37dd73 |
IEDL.DBID | .~1 |
ISSN | 0966-3274 1878-5492 |
IngestDate | Fri Jul 11 04:44:24 EDT 2025 Thu Apr 03 07:01:59 EDT 2025 Tue Jul 01 04:18:49 EDT 2025 Thu Apr 24 23:01:03 EDT 2025 Fri Feb 23 02:43:16 EST 2024 Wed Jun 18 06:48:29 EDT 2025 Tue Aug 26 17:03:02 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | microRNA-155 Acute graft-versus-host disease Polarization T lymphocyte Protein prenylation |
Language | English |
License | Copyright © 2021 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-9f9514b9e26f65acc697d50be067adf21d577288414e29e8306acc2e8fe37dd73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 34487810 |
PQID | 2570111131 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2570111131 pubmed_primary_34487810 crossref_primary_10_1016_j_trim_2021_101461 crossref_citationtrail_10_1016_j_trim_2021_101461 elsevier_sciencedirect_doi_10_1016_j_trim_2021_101461 elsevier_clinicalkeyesjournals_1_s2_0_S0966327421001015 elsevier_clinicalkey_doi_10_1016_j_trim_2021_101461 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-01 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Transplant immunology |
PublicationTitleAlternate | Transpl Immunol |
PublicationYear | 2021 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Testa, Pelosi, Castelli, Labbaye (bb0115) 2017; 3 Mashima (bb0120) 2015; 145 Ranganathan, Heaphy, Costinean, Stauffer, Na, Hamadani, Santhanam, Mao, Taylor, Sandhu, He, Shana’ah, Nuovo, Lagana, Cascione, Obad, Broom, Kauppinen, Byrd, Caligiuri, Perrotti, Hadley, Marcucci, Devine, Blazar, Croce, Garzon (bb0105) 2012; 119 Jing, Guo, Bao, Li, Lin, Lu, Wang (bb0215) 2017; 35 Youssef, Stuve, Patarroyo, Ruiz, Radosevich, Hur, Bravo, Mitchell, Sobel, Steinman, Zamvil (bb0205) 2002; 420 Kappel, Goldberg, King, Suh, Smith, Ligh, Holland, Grubin, Mark, Liu, Iwakura, Heller, van den Brink (bb0175) 2009; 113 Liu, Wang, Saijilafu, Zhang, Zhou (bb0160) 2013; 27 Zhang, Casey (bb0060) 1996; 65 Mausner-Fainberg, Luboshits, Mor, Maysel-Auslender, Rubinstein, Keren, George (bb0210) 2008; 197 Leng, Pan, Qin, Chen, Ye (bb0030) 2011; 22 Carlson, West, Coghill, Panoskaltsis-Mortari, Blazar, Serody (bb0170) 2009; 113 Jury, Isenberg, Mauri, Ehrenstein (bb0075) 2006; 177 Etna, Sinigaglia, Grassi, Giacomini, Romagnoli, Pardini, Severa, Cruciani, Rizzo, Anastasiadou, Di Camillo, Barzon, Fimia, Manganelli, Coccia (bb0125) 2018; 14 Zitzer, Snyder, Meng, Taylor, Efebera, Devine, Blazar, Garzon, Ranganathan (bb0100) 2018; 200 Zeiser, Blazar (bb0010) 2017; 377 Konstantinopoulos, Karamouzis, Papavassiliou (bb0055) 2007; 6 Hechinger, Maas, Durr, Leonhardt, Prinz, Marks, Gerlach, Hofmann, Fisch, Finke, Pircher, Zeiser (bb0080) 2013; 98 Marsolier, Pineau, Medjkane, Perichon, Yin, Flemington, Weitzman, Weitzman (bb0165) 2013; 9 Holstein, Hohl (bb0195) 2012; 12 Ghorpade, Leyland, Kurowska-Stolarska, Patil, Balaji (bb0130) 2012; 32 Ebert, Sharp (bb0155) 2012; 149 Berg, Rusch, Vartak, Jungst, Schauss, Waldmann, Hedberg, Pallasch, Bastiaens, Hallek, Wendtner, Frenzel (bb0135) 2015; 125 Xiao, Wang, Li, Baker, Guo, Corbet, Tsalik, Li, Palmer, Woods, Li, Chao, He (bb0035) 2013; 122 Ferrara, Levine, Reddy, Holler (bb0005) 2009; 373 Yu, Wang, Liu, Kaosaard, Semple, Anasetti, Yu (bb0180) 2011; 118 Zeiser, Youssef, Baker, Kambham, Steinman, Negrin (bb0200) 2007; 110 Zhang R, Wang X, Hong M, Luo T, Zhao M, Shen H, Fang J, Li X, Zang S, Chen P, Nie D, Zheng P, Wu Q, Xia L (2017) Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Oncotarget 8 (14):23360-23375. Doi Chen, Smith, Iype, Prestipino, Pfeifer, Grundmann, Schmitt-Graeff, Idzko, Beck, Prinz, Finke, Duyster, Zeiser (bb0045) 2015; 126 Na, Lee, Kang, Cho, Nam, Kim, Ha, Chung, Lee, Kwon, Koh, Kim (bb0070) 2004; 173 Thurnher, Gruenbacher (bb0065) 2015; 8 Zhao, He, Yang, Luo, Liu (bb0145) 2018; 21 Witzig, Tang, Micallef, Ansell, Link, Inwards, Porrata, Johnston, Colgan, Markovic, Nowakowski, Thompson, Allmer, Maurer, Gupta, Weiner, Hohl, Kurtin, Ding, Loegering, Schneider, Peterson, Habermann, Kaufmann (bb0190) 2011; 118 Resh (bb0050) 2006; 2 . Lewis, Burge, Bartel (bb0110) 2005; 120 Rodriguez, Vigorito, Clare, Warren, Couttet, Soond, van Dongen, Grocock, Das, Miska, Vetrie, Okkenhaug, Enright, Dougan, Turner, Bradley (bb0025) 2007; 316 Koumangoye, Andl, Taubenslag, Zilberman, Taylor, Loomans, Andl (bb0150) 2015; 14 Krenger, Snyder, Byon, Falzarano, Ferrara (bb0085) 1995; 155 Xiao, Rajewsky (bb0015) 2009; 136 Kaplan, Anderson, McNiff, Jain, Shlomchik, Shlomchik (bb0090) 2004; 173 Tili, Croce, Michaille (bb0020) 2009; 28 Berndt, Hamilton, Sebti (bb0185) 2011; 11 Korngold, Marini, de Baca, Murphy, Giles-Komar (bb0095) 2003; 9 Kong, Yang, He, Zhao, Coppola, Dalton, Cheng (bb0140) 2008; 28 10.1016/j.trim.2021.101461_bb0040 Na (10.1016/j.trim.2021.101461_bb0070) 2004; 173 Kong (10.1016/j.trim.2021.101461_bb0140) 2008; 28 Zhao (10.1016/j.trim.2021.101461_bb0145) 2018; 21 Ebert (10.1016/j.trim.2021.101461_bb0155) 2012; 149 Marsolier (10.1016/j.trim.2021.101461_bb0165) 2013; 9 Rodriguez (10.1016/j.trim.2021.101461_bb0025) 2007; 316 Leng (10.1016/j.trim.2021.101461_bb0030) 2011; 22 Jury (10.1016/j.trim.2021.101461_bb0075) 2006; 177 Berg (10.1016/j.trim.2021.101461_bb0135) 2015; 125 Zeiser (10.1016/j.trim.2021.101461_bb0010) 2017; 377 Xiao (10.1016/j.trim.2021.101461_bb0015) 2009; 136 Holstein (10.1016/j.trim.2021.101461_bb0195) 2012; 12 Liu (10.1016/j.trim.2021.101461_bb0160) 2013; 27 Carlson (10.1016/j.trim.2021.101461_bb0170) 2009; 113 Testa (10.1016/j.trim.2021.101461_bb0115) 2017; 3 Chen (10.1016/j.trim.2021.101461_bb0045) 2015; 126 Ranganathan (10.1016/j.trim.2021.101461_bb0105) 2012; 119 Hechinger (10.1016/j.trim.2021.101461_bb0080) 2013; 98 Krenger (10.1016/j.trim.2021.101461_bb0085) 1995; 155 Zeiser (10.1016/j.trim.2021.101461_bb0200) 2007; 110 Resh (10.1016/j.trim.2021.101461_bb0050) 2006; 2 Mausner-Fainberg (10.1016/j.trim.2021.101461_bb0210) 2008; 197 Ferrara (10.1016/j.trim.2021.101461_bb0005) 2009; 373 Jing (10.1016/j.trim.2021.101461_bb0215) 2017; 35 Mashima (10.1016/j.trim.2021.101461_bb0120) 2015; 145 Berndt (10.1016/j.trim.2021.101461_bb0185) 2011; 11 Youssef (10.1016/j.trim.2021.101461_bb0205) 2002; 420 Konstantinopoulos (10.1016/j.trim.2021.101461_bb0055) 2007; 6 Etna (10.1016/j.trim.2021.101461_bb0125) 2018; 14 Kaplan (10.1016/j.trim.2021.101461_bb0090) 2004; 173 Zitzer (10.1016/j.trim.2021.101461_bb0100) 2018; 200 Xiao (10.1016/j.trim.2021.101461_bb0035) 2013; 122 Tili (10.1016/j.trim.2021.101461_bb0020) 2009; 28 Thurnher (10.1016/j.trim.2021.101461_bb0065) 2015; 8 Yu (10.1016/j.trim.2021.101461_bb0180) 2011; 118 Korngold (10.1016/j.trim.2021.101461_bb0095) 2003; 9 Koumangoye (10.1016/j.trim.2021.101461_bb0150) 2015; 14 Kappel (10.1016/j.trim.2021.101461_bb0175) 2009; 113 Witzig (10.1016/j.trim.2021.101461_bb0190) 2011; 118 Lewis (10.1016/j.trim.2021.101461_bb0110) 2005; 120 Ghorpade (10.1016/j.trim.2021.101461_bb0130) 2012; 32 Zhang (10.1016/j.trim.2021.101461_bb0060) 1996; 65 |
References_xml | – volume: 27 start-page: 1473 year: 2013 end-page: 1483 ident: bb0160 article-title: MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration publication-title: Genes Dev. – volume: 125 start-page: 2948 year: 2015 end-page: 2957 ident: bb0135 article-title: miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL publication-title: Blood – reference: Zhang R, Wang X, Hong M, Luo T, Zhao M, Shen H, Fang J, Li X, Zang S, Chen P, Nie D, Zheng P, Wu Q, Xia L (2017) Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Oncotarget 8 (14):23360-23375. Doi: – volume: 65 start-page: 241 year: 1996 end-page: 269 ident: bb0060 article-title: Protein prenylation: molecular mechanisms and functional consequences publication-title: Annu. Rev. Biochem. – volume: 8 year: 2015 ident: bb0065 article-title: T lymphocyte regulation by mevalonate metabolism publication-title: Sci. Signal. – volume: 126 start-page: 103 year: 2015 end-page: 112 ident: bb0045 article-title: MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation publication-title: Blood – volume: 155 start-page: 585 year: 1995 end-page: 593 ident: bb0085 article-title: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 118 start-page: 4882 year: 2011 end-page: 4889 ident: bb0190 article-title: Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas publication-title: Blood – volume: 316 start-page: 608 year: 2007 end-page: 611 ident: bb0025 article-title: Requirement of bic/microRNA-155 for normal immune function publication-title: Science (New York, N.Y.) – volume: 118 start-page: 5011 year: 2011 end-page: 5020 ident: bb0180 article-title: Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice publication-title: Blood – volume: 6 start-page: 541 year: 2007 end-page: 555 ident: bb0055 article-title: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets publication-title: Nat. Rev. Drug Discov. – volume: 200 start-page: 4170 year: 2018 end-page: 4179 ident: bb0100 article-title: MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion, migration, and effector function publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 122 start-page: 3365 year: 2013 end-page: 3375 ident: bb0035 article-title: Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease publication-title: Blood – volume: 22 start-page: 141 year: 2011 end-page: 147 ident: bb0030 article-title: Role of microRNA-155 in autoimmunity publication-title: Cytokine Growth Factor Rev. – volume: 32 start-page: 2239 year: 2012 end-page: 2253 ident: bb0130 article-title: MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages publication-title: Mol. Cell. Biol. – volume: 21 start-page: 112 year: 2018 end-page: 123 ident: bb0145 article-title: Histone Deacetylase-3 modification of MicroRNA-31 promotes cell proliferation and aerobic glycolysis in breast Cancer and is predictive of poor prognosis publication-title: J. Breast Cancer – volume: 119 start-page: 4786 year: 2012 end-page: 4797 ident: bb0105 article-title: Regulation of acute graft-versus-host disease by microRNA-155 publication-title: Blood – volume: 3 year: 2017 ident: bb0115 article-title: miR-146 and miR-155: two key modulators of immune response and tumor development. Non-coding publication-title: RNA – volume: 2 start-page: 584 year: 2006 end-page: 590 ident: bb0050 article-title: Trafficking and signaling by fatty-acylated and prenylated proteins publication-title: Nat. Chem. Biol. – volume: 110 start-page: 4588 year: 2007 end-page: 4598 ident: bb0200 article-title: Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity publication-title: Blood – volume: 14 year: 2018 ident: bb0125 article-title: Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells publication-title: PLoS Pathog. – volume: 173 start-page: 5467 year: 2004 end-page: 5475 ident: bb0090 article-title: Target antigens determine graft-versus-host disease phenotype publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 113 start-page: 1365 year: 2009 end-page: 1374 ident: bb0170 article-title: In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations publication-title: Blood – volume: 12 start-page: 704 year: 2012 end-page: 709 ident: bb0195 article-title: Is there a future for prenyltransferase inhibitors in cancer therapy? publication-title: Curr. Opin. Pharmacol. – volume: 377 start-page: 2167 year: 2017 end-page: 2179 ident: bb0010 article-title: Acute graft-versus-host disease - biologic process, prevention, and therapy publication-title: N. Engl. J. Med. – volume: 98 start-page: 31 year: 2013 end-page: 40 ident: bb0080 article-title: Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells publication-title: Haematologica – volume: 420 start-page: 78 year: 2002 end-page: 84 ident: bb0205 article-title: The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease publication-title: Nature – volume: 28 start-page: 264 year: 2009 end-page: 284 ident: bb0020 article-title: miR-155: on the crosstalk between inflammation and cancer publication-title: Int. Rev. Immunol. – volume: 197 start-page: 829 year: 2008 end-page: 839 ident: bb0210 article-title: The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells publication-title: Atherosclerosis – volume: 177 start-page: 7416 year: 2006 end-page: 7422 ident: bb0075 article-title: Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 373 start-page: 1550 year: 2009 end-page: 1561 ident: bb0005 article-title: Graft-versus-host disease publication-title: Lancet (London, England) – volume: 145 start-page: 323 year: 2015 end-page: 333 ident: bb0120 article-title: Physiological roles of miR-155 publication-title: Immunology – volume: 14 start-page: 24 year: 2015 ident: bb0150 article-title: SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells publication-title: Mol. Cancer – volume: 9 start-page: 292 year: 2003 end-page: 303 ident: bb0095 article-title: Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses publication-title: Biology of blood and marrow transplantation – volume: 11 start-page: 775 year: 2011 end-page: 791 ident: bb0185 article-title: Targeting protein prenylation for cancer therapy publication-title: Nat. Rev. Cancer – reference: . – volume: 136 start-page: 26 year: 2009 end-page: 36 ident: bb0015 article-title: MicroRNA control in the immune system: basic principles publication-title: Cell – volume: 113 start-page: 945 year: 2009 end-page: 952 ident: bb0175 article-title: IL-17 contributes to CD4-mediated graft-versus-host disease publication-title: Blood – volume: 120 start-page: 15 year: 2005 end-page: 20 ident: bb0110 article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets publication-title: Cell – volume: 35 year: 2017 ident: bb0215 article-title: Pitavastatin up-regulates eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells publication-title: Cardiovasc. Ther. – volume: 173 start-page: 1276 year: 2004 end-page: 1283 ident: bb0070 article-title: Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 9 year: 2013 ident: bb0165 article-title: OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes publication-title: PLoS Pathog. – volume: 28 start-page: 6773 year: 2008 end-page: 6784 ident: bb0140 article-title: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA publication-title: Mol. Cell. Biol. – volume: 149 start-page: 515 year: 2012 end-page: 524 ident: bb0155 article-title: Roles for microRNAs in conferring robustness to biological processes publication-title: Cell – volume: 9 issue: 4 year: 2013 ident: 10.1016/j.trim.2021.101461_bb0165 article-title: OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003222 – volume: 113 start-page: 945 issue: 4 year: 2009 ident: 10.1016/j.trim.2021.101461_bb0175 article-title: IL-17 contributes to CD4-mediated graft-versus-host disease publication-title: Blood doi: 10.1182/blood-2008-08-172155 – volume: 35 issue: 5 year: 2017 ident: 10.1016/j.trim.2021.101461_bb0215 article-title: Pitavastatin up-regulates eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells publication-title: Cardiovasc. Ther. doi: 10.1111/1755-5922.12282 – volume: 28 start-page: 264 issue: 5 year: 2009 ident: 10.1016/j.trim.2021.101461_bb0020 article-title: miR-155: on the crosstalk between inflammation and cancer publication-title: Int. Rev. Immunol. doi: 10.1080/08830180903093796 – volume: 145 start-page: 323 issue: 3 year: 2015 ident: 10.1016/j.trim.2021.101461_bb0120 article-title: Physiological roles of miR-155 publication-title: Immunology doi: 10.1111/imm.12468 – volume: 125 start-page: 2948 issue: 19 year: 2015 ident: 10.1016/j.trim.2021.101461_bb0135 article-title: miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL publication-title: Blood doi: 10.1182/blood-2014-07-586511 – volume: 21 start-page: 112 issue: 2 year: 2018 ident: 10.1016/j.trim.2021.101461_bb0145 article-title: Histone Deacetylase-3 modification of MicroRNA-31 promotes cell proliferation and aerobic glycolysis in breast Cancer and is predictive of poor prognosis publication-title: J. Breast Cancer doi: 10.4048/jbc.2018.21.2.112 – volume: 11 start-page: 775 issue: 11 year: 2011 ident: 10.1016/j.trim.2021.101461_bb0185 article-title: Targeting protein prenylation for cancer therapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3151 – volume: 119 start-page: 4786 issue: 20 year: 2012 ident: 10.1016/j.trim.2021.101461_bb0105 article-title: Regulation of acute graft-versus-host disease by microRNA-155 publication-title: Blood doi: 10.1182/blood-2011-10-387522 – volume: 316 start-page: 608 issue: 5824 year: 2007 ident: 10.1016/j.trim.2021.101461_bb0025 article-title: Requirement of bic/microRNA-155 for normal immune function publication-title: Science (New York, N.Y.) doi: 10.1126/science.1139253 – volume: 177 start-page: 7416 issue: 10 year: 2006 ident: 10.1016/j.trim.2021.101461_bb0075 article-title: Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 22 start-page: 141 issue: 3 year: 2011 ident: 10.1016/j.trim.2021.101461_bb0030 article-title: Role of microRNA-155 in autoimmunity publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2011.05.002 – volume: 32 start-page: 2239 issue: 12 year: 2012 ident: 10.1016/j.trim.2021.101461_bb0130 article-title: MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.06597-11 – volume: 118 start-page: 5011 issue: 18 year: 2011 ident: 10.1016/j.trim.2021.101461_bb0180 article-title: Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice publication-title: Blood doi: 10.1182/blood-2011-03-340315 – volume: 373 start-page: 1550 issue: 9674 year: 2009 ident: 10.1016/j.trim.2021.101461_bb0005 article-title: Graft-versus-host disease publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(09)60237-3 – volume: 9 start-page: 292 issue: 5 year: 2003 ident: 10.1016/j.trim.2021.101461_bb0095 article-title: Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses publication-title: Biology of blood and marrow transplantation doi: 10.1016/S1083-8791(03)00087-9 – volume: 377 start-page: 2167 issue: 22 year: 2017 ident: 10.1016/j.trim.2021.101461_bb0010 article-title: Acute graft-versus-host disease - biologic process, prevention, and therapy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1609337 – volume: 200 start-page: 4170 issue: 12 year: 2018 ident: 10.1016/j.trim.2021.101461_bb0100 article-title: MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion, migration, and effector function publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 118 start-page: 4882 issue: 18 year: 2011 ident: 10.1016/j.trim.2021.101461_bb0190 article-title: Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas publication-title: Blood doi: 10.1182/blood-2011-02-334904 – volume: 173 start-page: 5467 issue: 9 year: 2004 ident: 10.1016/j.trim.2021.101461_bb0090 article-title: Target antigens determine graft-versus-host disease phenotype publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 173 start-page: 1276 issue: 2 year: 2004 ident: 10.1016/j.trim.2021.101461_bb0070 article-title: Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation publication-title: J. Immunol. (Baltimore, Md : 1950) – volume: 149 start-page: 515 issue: 3 year: 2012 ident: 10.1016/j.trim.2021.101461_bb0155 article-title: Roles for microRNAs in conferring robustness to biological processes publication-title: Cell doi: 10.1016/j.cell.2012.04.005 – volume: 110 start-page: 4588 issue: 13 year: 2007 ident: 10.1016/j.trim.2021.101461_bb0200 article-title: Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity publication-title: Blood doi: 10.1182/blood-2007-08-106005 – volume: 122 start-page: 3365 issue: 19 year: 2013 ident: 10.1016/j.trim.2021.101461_bb0035 article-title: Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease publication-title: Blood doi: 10.1182/blood-2013-06-510586 – volume: 155 start-page: 585 issue: 2 year: 1995 ident: 10.1016/j.trim.2021.101461_bb0085 article-title: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease publication-title: J. Immunol. (Baltimore, Md : 1950) – ident: 10.1016/j.trim.2021.101461_bb0040 doi: 10.18632/oncotarget.15579 – volume: 113 start-page: 1365 issue: 6 year: 2009 ident: 10.1016/j.trim.2021.101461_bb0170 article-title: In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations publication-title: Blood doi: 10.1182/blood-2008-06-162420 – volume: 14 issue: 1 year: 2018 ident: 10.1016/j.trim.2021.101461_bb0125 article-title: Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1006790 – volume: 98 start-page: 31 issue: 1 year: 2013 ident: 10.1016/j.trim.2021.101461_bb0080 article-title: Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells publication-title: Haematologica doi: 10.3324/haematol.2012.065789 – volume: 136 start-page: 26 issue: 1 year: 2009 ident: 10.1016/j.trim.2021.101461_bb0015 article-title: MicroRNA control in the immune system: basic principles publication-title: Cell doi: 10.1016/j.cell.2008.12.027 – volume: 8 issue: 370 year: 2015 ident: 10.1016/j.trim.2021.101461_bb0065 article-title: T lymphocyte regulation by mevalonate metabolism publication-title: Sci. Signal. doi: 10.1126/scisignal.2005970 – volume: 126 start-page: 103 issue: 1 year: 2015 ident: 10.1016/j.trim.2021.101461_bb0045 article-title: MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation publication-title: Blood doi: 10.1182/blood-2014-12-617258 – volume: 14 start-page: 24 year: 2015 ident: 10.1016/j.trim.2021.101461_bb0150 article-title: SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells publication-title: Mol. Cancer doi: 10.1186/s12943-014-0284-y – volume: 2 start-page: 584 issue: 11 year: 2006 ident: 10.1016/j.trim.2021.101461_bb0050 article-title: Trafficking and signaling by fatty-acylated and prenylated proteins publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio834 – volume: 28 start-page: 6773 issue: 22 year: 2008 ident: 10.1016/j.trim.2021.101461_bb0140 article-title: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.00941-08 – volume: 27 start-page: 1473 issue: 13 year: 2013 ident: 10.1016/j.trim.2021.101461_bb0160 article-title: MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration publication-title: Genes Dev. doi: 10.1101/gad.209619.112 – volume: 6 start-page: 541 issue: 7 year: 2007 ident: 10.1016/j.trim.2021.101461_bb0055 article-title: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2221 – volume: 12 start-page: 704 issue: 6 year: 2012 ident: 10.1016/j.trim.2021.101461_bb0195 article-title: Is there a future for prenyltransferase inhibitors in cancer therapy? publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2012.06.013 – volume: 197 start-page: 829 issue: 2 year: 2008 ident: 10.1016/j.trim.2021.101461_bb0210 article-title: The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.07.031 – volume: 120 start-page: 15 issue: 1 year: 2005 ident: 10.1016/j.trim.2021.101461_bb0110 article-title: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets publication-title: Cell doi: 10.1016/j.cell.2004.12.035 – volume: 3 issue: 3 year: 2017 ident: 10.1016/j.trim.2021.101461_bb0115 article-title: miR-146 and miR-155: two key modulators of immune response and tumor development. Non-coding publication-title: RNA – volume: 420 start-page: 78 issue: 6911 year: 2002 ident: 10.1016/j.trim.2021.101461_bb0205 article-title: The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease publication-title: Nature doi: 10.1038/nature01158 – volume: 65 start-page: 241 year: 1996 ident: 10.1016/j.trim.2021.101461_bb0060 article-title: Protein prenylation: molecular mechanisms and functional consequences publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.bi.65.070196.001325 |
SSID | ssj0002597 |
Score | 2.3044426 |
Snippet | MicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T lymphocyte... AbstractMicroRNA-155(miR-155) and protein prenylation have been reported to participate in acute graft-versus-host disease (aGVHD) through modulating T... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 101461 |
SubjectTerms | Acute Disease Acute graft-versus-host disease Allergy and Immunology Animals Feedback Graft vs Host Disease Mice Mice, Inbred C57BL microRNA-155 MicroRNAs - genetics Polarization Protein Prenylation T lymphocyte T-Lymphocytes, Regulatory |
Title | Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0966327421001015 https://www.clinicalkey.es/playcontent/1-s2.0-S0966327421001015 https://dx.doi.org/10.1016/j.trim.2021.101461 https://www.ncbi.nlm.nih.gov/pubmed/34487810 https://www.proquest.com/docview/2570111131 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhAXBOW1PCojcUNh48RxkmO1otoCrVDZSr1ZtmPTwJJdJVmkXvhF_EhmYmcRghaJk5VoLDuZ8Tzkb2YIeelKpzNVqShVZRpxlrtIVylEKabkxsZwoIbOc8cnYn7G355n5ztkNubCIKwy6H6v0wdtHd5Mw9-crut6-hGcb5HiTSMbCqVhojnnOUr56--_YB7g3g8p00AcIXVInPEYr76tMRs9YfiCC3aVcbrK-RyM0OFdcid4j_TAb_Ae2bHNHrnp-0le7pFbx-Gm_D75cdRc1HrAY9GVo-Dm0a_1aQR2naqmokN5hrqhWNHy0sPhqANDppX5Qper1Zpij5VvwDdbUWU2vaWfWuX6CFEcmy7C3BAaLndo6PVDW9_XHozhsJ5G1KSB0UPB6IJe2OXatpTlwx4WQE_x4qB7QM4O3yxm8yh0ZogMF0kflQ4cM65LmwgnMmWMKPMqi7UF26cql7AqA6-9KDjjNiltAXEJECW2cDbNqypPH5LdZtXYx4QyIxzTsYbISHPhlE7zUhgIzJXmWRIXE8JGlkgTypZj94ylHPFpnyWyUSIbpWfjhLzazln7oh3XUqcjp-WYjgoKVIJNuXZW_rdZtgs6oJNMdomM5R9yOiHZduZvov7PFV-MYihBByB_VGNXm05iJ0I0fSnQPPLyuf3uFOLvvGDxk_9c9Sm5jU8ewfOM7Pbtxj4HP6zX-8NB2yc3Dman7z_gePRufvITvTkzmg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJz5eEAwY5dNIvKGocew4yeM0MbVs7QN00t4s27FZoEuqJkXa_8QfyTl2KiHYkHiK5NzJTs6-D_l3dwi9t4VVqSxlRGVBI0YyG6mSQpSiC6ZNDAeq7zw3X_DpOft0kV7soeMhF8bBKoPu9zq919ZhZBL-5mRdVZMv4Hxz6m4aSV8oLb2D9l11qnSE9o9mp9PFTiGDh99nTQN95BhC7oyHeXWbyiWkJ8QNME5usk83-Z-9HTp5hB4GBxIf-TU-RnumPkB3fUvJ6wN0bx4uy5-gn7P6slI9JAs3FoOnh6-qzxGYdizrEvcVGqoau6KW1x4Rhy3YMiX1d7xqmjV2bVZ-gOhMiaXedgZ_3UjbRQ7IsW0jlx6Cw_0ODu1-8Ma3tgd72M-nHHBSw9OjwfASX5rV2mwwyfo1LIEeu7uD9ik6P_m4PJ5GoTlDpBlPuqiw4JsxVZiEW55KrXmRlWmsDJg_WdqElCk47nnOCDNJYXIITYAoMbk1NCvLjD5Do7qpzXOEieaWqFhBcKQYt1LRrOAaYnOpWJrE-RiRQSRCh8rlroHGSgwQtW_CiVE4MQovxjH6sONZ-7odt1LTQdJiyEgFHSrArNzKlf2Ny7RBDbSCiDYRsfhjq45RuuP8bbf_c8Z3wzYUoAacfGRtmm0rXDNCZ_0o0Bz6_bn7bgoheJaT-MV_zvoW3Z8u52fibLY4fYkeuDce0PMKjbrN1rwGt6xTb8Kx-wWKKDS2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+the+miR-155+and+protein+prenylation+feedback+loop+alleviated+acute+graft-versus-host+disease+through+regulating+the+balance+between+T+helper+17+and+Treg+cells&rft.jtitle=Transplant+immunology&rft.au=Wang%2C+Xiaoxiao&rft.au=Zhang%2C+Ran&rft.au=Huang%2C+Zhenli&rft.au=Zang%2C+Sibin&rft.date=2021-12-01&rft.issn=0966-3274&rft.volume=69&rft.spage=101461&rft.epage=101461&rft_id=info:doi/10.1016%2Fj.trim.2021.101461&rft.externalDBID=ECK1-s2.0-S0966327421001015&rft.externalDocID=1_s2_0_S0966327421001015 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09663274%2FS0966327421X00068%2Fcov150h.gif |